Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 15Neoplasms 11Multiple Myeloma 9Colorectal Neoplasms 8Myelodysplastic Syndromes 7Leukemia, Myeloid, Acute 6Glioblastoma 5Sarcoma 4Prostatic Neoplasms 4Neoplasms, Plasma Cell 4Leukemia, Myelomonocytic, Chronic 4Carcinoma, Non-Small-Cell Lung 4Inflammation 3Breast Neoplasms 3Stomatitis 2Stomach Neoplasms 2Skin Neoplasms 2Primary Myelofibrosis 2Ovarian Neoplasms 2Neoplasms by Site 2Myofibroma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Liver Neoplasms 2Leukemia 2Glioma 2Frailty 2Digestive System Neoplasms 2Digestive System Diseases 2

Interventions

Oxaliplatin 3Magnetic Resonance Spectroscopy 3Exercise Test 2Cyclophosphamide 2Capecitabine 2trifluridine tipiracil drug combination 1penpulimab 1pembrolizumab 1lutetium Lu 177 dotatate 1huachansu 1guadecitabine 1copper dotatate CU-64 1XELOX 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Restraint, Physical 1Physical Examination 1Oviposition 1Observation 1Lutetium-177 1Lutetium 1Irinotecan 1Indocyanine Green 1Hyperthermic Intraperitoneal Chemotherapy 1Health Information Exchange 1Gemcitabine 1Gastroscopy 1Fluorouracil 1Fluorescein 1Endoscopy, Digestive System 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Diseases × Ascorbic Acid × Clear all
NCT01550510 2025-05-06

Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA

Thomas Jefferson University

Phase 1/2 Terminated
4 enrolled 5 charts
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡